Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Hao Ying Xu"'
Autor:
Hao Ying Xu, Wei Liu, Feng Gu, Bin Zou, Wai Ling Chan, Paul W. Smith, Kah Fei Wan, Ratna Karuna, Agatha Susila, Peck Gee Seah, Andy Yip, Pei Yong Shi, Trixie Wagner, Thierry T. Diagana, Qing Yin Wang, Alex Chao, Mei Ding, Hongping Dong, Seh Yong Leong, Francesca Blasco, Katherine Chan, Shahul Nilar, Ina Dix
Publikováno v:
ACS Medicinal Chemistry Letters. 6:344-348
Spiropyrazolopyridone 1 was identified, as a novel dengue virus (DENV) inhibitor, from a DENV serotype 2 (DENV-2) high-throughput phenotypic screen. As a general trend within this chemical class, chiral resolution of the racemate revealed that R enan
Autor:
Hao Ying Xu, Michal Tichý, Radek Pohl, Fumiaki Yokokawa, Michal Hocek, Pei Yong Shi, Yen Liang Chen
Publikováno v:
Bioorganic & Medicinal Chemistry. 20:6123-6133
A series of new pyrimido[4,5-b]indole ribonucleosides bearing phenyl or hetaryl group at position 4 has been prepared by selective Pd-catalyzed cross-coupling reactions of the corresponding protected 4,6-dichloropyrimido[4,5-b]indole ribonucleoside w
Autor:
Laura D. Kramer, Qing Yin Wang, Hao Ying Xu, Zhiming Yuan, Min Qing, Xuping Xie, Pei Yong Shi
Publikováno v:
Journal of Virology. 85:11183-11195
We report a novel inhibitor that selectively suppresses dengue virus (DENV) by targeting viral NS4B protein. The inhibitor was identified by screening a 1.8-million-compound library using a luciferase replicon of DENV serotype 2 (DENV-2). The compoun
Publikováno v:
Antiviral Research. 91:11-19
To facilitate dengue virus (DENV) drug discovery, we developed a stable luciferase reporter DENV-2. A renilla luciferase gene was engineered into the capsid-coding region of an infectious cDNA clone of DENV-2. Transfection of BHK-21 cells with the cD
Publikováno v:
Antimicrobial Agents and Chemotherapy. 54:3686-3695
Brequinar is an inhibitor of dihydroorotate dehydrogenase, an enzyme that is required for de novo pyrimidine biosynthesis. Here we report that brequinar has activity against a broad spectrum of viruses. The compound not only inhibits flaviviruses (de
Autor:
Suresh B. Lakshminarayana, Andy Yip, Anne Goh, Margaret Weaver, Wouter Schul, Boping Liu, Yen Liang Chen, Hao Ying Xu, Min Qing, Véronique Dartois, Thomas H. Keller, Pei Yong Shi, Zheng Yin, Jeyaraj Duraiswamy, Ravinder Reddi Kondreddi
Publikováno v:
Antimicrobial Agents and Chemotherapy. 54:3255-3261
Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen that infects humans. Neither a vaccine nor an antiviral therapy is currently available for DENV. Here, we report an adenosine nucleoside prodrug that potently inhibits DENV repli
Autor:
Wai Ling Chan, Bo Zhang, Thomas H. Keller, Wouter Schul, Min Qing, Pei Yong Shi, Andy Yip, Kristen A. Bernard, Gang Zou, Hao Ying Xu, Suresh B. Lakshminarayana, Gang Wang, Anne Goh, Wei Liu, Min Dong, Boping Liu, Hui Pen Tan, Handan He, Qing Yin Wang, Margaret Weaver, Feng Gu, Yen Liang Chen, Zheng Yin, Pornwaratt Niyomrattanakit, Chuan Young Ng, Arkadius Pichota, Christine E. Garrett, Véronique Dartois, Joanne Y.H. Lim, Ravinder Reddy Kondreddi, Jeyaraj Duraiswamy, Kai Lin, Chin Chin Lim, Karen Beltz
Publikováno v:
Proceedings of the National Academy of Sciences. 106:20435-20439
Dengue virus (DENV), a mosquito-borne flavivirus, is a major public health threat. The virus poses risk to 2.5 billion people worldwide and causes 50 to 100 million human infections each year. Neither a vaccine nor an antiviral therapy is currently a
Autor:
Feng Gu, Mee Kian Poh, Wai Yee Phong, Subhash G. Vasudevan, Edgar Jacoby, Olivier Heudi, Hao Ying Xu, Deana Jaber, Sejal J. Patel, Ngai Ling Ma, Ranga Rao, Wouter Schul, Eric Vangrevelinghe, Thomas H. Keller, Qing-Yin Wang
Publikováno v:
Antimicrobial Agents and Chemotherapy. 53:1823-1831
The incidence of dengue fever epidemics has increased dramatically over the last few decades. However, no vaccine or antiviral therapies are available. Therefore, the need for safe and effective antiviral drugs has become imperative. The entry of den
Autor:
Qing Yin Wang, Yen Liang Chen, Hao Ying Xu, K.L. Yeo, Hongping Dong, Pei Yong Shi, Fumiaki Yokokawa
Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen in humans. Currently, there is no clinically approved vaccine or antiviral for DENV. Combination therapy is a common practice in antiviral treatment and a potential approach to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b129686c93da4981fbfe43c7a79a692
https://europepmc.org/articles/PMC4356831/
https://europepmc.org/articles/PMC4356831/
Publikováno v:
Chinese Journal of Integrative Medicine. 10:162-169